Haim Ovadia
Jerusalem, JM 91120, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants.
Journal: International journal of molecular sciences
Published: November 27, 2023
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis.
Journal: JACS Au
Published: November 05, 2021
MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
Journal: Journal of autoimmunity
Published: June 09, 2021
QKI-V5 is downregulated in CNS inflammatory demyelinating diseases.
Journal: Multiple sclerosis and related disorders
Published: September 12, 2019
Genetic prion disease: no role for the immune system in disease pathogenesis?
Journal: Human molecular genetics
Published: March 27, 2018
Androgen receptor: a potential therapeutic target for glioblastoma.
Journal: Oncotarget
Published: November 15, 2017
Prestin autoantibodies screening in idiopathic sudden sensorineural hearing loss.
Journal: European annals of otorhinolaryngology, head and neck diseases
Published: October 14, 2017
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Journal: International journal of nanomedicine
Published: December 10, 2015
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Journal: Multiple sclerosis and related disorders
Published: November 10, 2015
Electrical stimulation of the amygdala modifies the negative feedback effect of glucocorticoids on the adrenocortical responses to stress.
Journal: Neuroimmunomodulation
Published: March 16, 2015
Last Updated: 09/26/2026